After a public hearing on Friday where researchers and health professionals urged the FDA to increase research into cannabis, FDA official Dr. Amy Abernethy tweeted, “We will work as quickly as possible to define a way forward.” The FDA is accepting further comments on a docket until July 2; it then plans to convene a workgroup co-chaired by Abernethy and Lowell Schiller to examine its next steps. http://bit.ly/2WevL9M
